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Gliotoxin Mediated Apoptotic Cell Death in Jurkat cells
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Introduction: In the immunocompromised host invasive aspergillo-
sis (IA) is an increasing problem with high mortality despite new
and improved antifungals. The mycotoxin gliotoxin is secreted dur-
ing hyphal growth of Aspergillus fumigatus. The toxin is detected in
the serum of patients with proven IA. Gliotoxin is immunosuppres-
sive and mediates proliferation, apoptosis and necrosis of different
cell-types. Its exact role in the pathogenesis of IA is still debated.
Objectives: We wanted to further investigate the effect of
gliotoxin on T-cells by studying death responses in the T cell line
Jurkat E6 induced by this toxin.
Methods: Jurkat E6 cells were incubated with or without 50-
2000ng/ml gliotoxin for 1 to 24 hours. Apoptotic cells death was
determined using Annexin-V-FLUOS and propidium iodide (PI) stain-
ing. Analysis of active caspase 3, -8 and -9 were performed using
selective antibodies, loss of mitochondrial membrane potential by
JC-1 staining, and ROS production using hydroethidine staining af-
ter incubation with gliotoxin 250ng/ml for 4 hours. All assessments
were performed by flow cytometry. Staurosporine (1µM for 2 hours)
was used as positive control.
Results: We observed time- and concentration dependent cell
death in response to gliotoxin. Annexin V Fluos and PI staining sug-
gested apoptotic cell death with a maximal response after 4 to
6 hours of incubation with 500ng/ml gliotoxin. Furthermore, cell
death was almost completely blocked by the pan-caspase inhibitor
Z-VAD-FMK (100µM). After 4 hour incubation with gliotoxin, we
found caspase-3 activation (27-48% positive cells), caspase-9 ac-
tivation (21-54% positive cells) and cells with loss of mitochondrial
membrane potential (49-78%) suggesting apoptosis and mitochon-
drial involvement. We also found activation of caspase-8 (20-52%
positive cells) suggesting an involvement of death receptor path-
way as well. ROS generation was detected in less than 10% of the
cells after treatment.
Conclusions: Our data show a caspase dependent apoptotic cell
death of Jurkat T cells in presence of gliotoxin. This T cell apopto-
sis may contribute to reduced immunity to the fungus.
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Prevalence of Virulence Factors and Antimicrobial
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Background: E. coli is the most frequent etiologic agent of urinary
tract infection (UTI). There are limited data comparing the preva-
lence of virulence factors in UPEC isolates from immunocompetent
and immunocompromised hosts.
Objectives: To compare the prevalence of virulence factors and
antimicrobial resistance in UPEC strains isolated from immunocom-
promised and immunocompetent subjects.
Materials and Methods: UPEC isolates were characterized ac-
cording to serotype, hemolytic and hemagglutination properties,
virulence determinant genes (pap1/pap2, sfa1/sfa2, afa1/afa2
hly1/hly2, aer1/aer2,cnf1/cnf2) and antimicrobial susceptibility.
Clinical presentation and patients' characteristics were abstracted
from charts.
Results: UPEC isolates from 36 immunocompromised patients (26
renal and 1 liver transplant recipients, 1 AIDS patient and other
8 subjects receiving immunossupressive therapy) and 27 immuno-
competent subjects with UTI were studied. Secondary bacteremia
occurred only in immunocompromised hosts (7 cases, p=0.02). Re-
sistance to quinolones tended to be less frequent among these pa-
tients (OR1.70; 95% IC=0.91-3.14, p=0.096). There was no signif-
icant difference between groups in the prevalence of resistance
to other antimicrobial drugs. There was no significant difference
between groups in the distribution of O-H serotypes, mannose re-
sistant or sensitive hemagglutination, and virulence determinant
genes. Quinolone resistance was associated with a lower preva-
lence of alfa-hemolysis (p=0.01), O serotypes classically associated
with pyelonephritis (p=0.017), and sfa1/sfa2 gene (p=0.003).
Conclusions: Despite the higher frequency of secondary bac-
teremia among immunocompromised patients there was no signifi-
cant difference in the prevalence of virulence factors in UPEC iso-
lates from these patients as compared with isolates from immuno-
competent controls. Quinolone resistance was associated with a
lower prevalence of virulence factors.
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Hyperinfection Syndrome in an Immunocompromised Host
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Background: Strongyloidiasis has worldwide distribution and is one
of the most important enteric elminthic infections. In patients with
impaired cell mediated immunity, Strongyloides stercoralis may
disseminate to multiple organs and cause a life-threatening com-
plication called hyperinfection syndrome. Herein we present the
clinical course of an immunocompromised patient with Strongy-
loides hyperinfection syndrome.
Materials, Methods and Results: A 62 year old farmer was ad-
mitted to our department because of fever and severe headache
for the last 48 hours. He was on high dose of corticosteroids be-
cause of retroperitoneal fibrosis. On admission, he was lethar-
gic with nuchal rigidity. Cerebrospinal fluid (CSF) examination re-
vealed 4000 leukocytes/uL with neutrophil predominance (82%)
and CSF cultures grew Enterococcus feacalis. Blood and urine cul-
tures yielded no organism and the patient was treated with Ampi-
cilline and Gentamicin. Transesophageal echocardiogram and com-
puted tomography of abdomen and thorax, were negative. Two
days after initiation of treatment the patient was improved, but
on the 10th day he started vomiting. An upper endoscopy was per-
formed and jejunum biopsies revealed Strongyloides stercoralis.
On stool examination filariform larvae were seen. Bronchoalveolar
lavage as well as CSF sediment examination revealed filariform lar-
vae, so the diagnosis of hyperinfection syndrome was established.
The patient was treated with albendazole 400 mg BID, while corti-
costeroids were being tapered. Although the patient was on treat-
ment, the stool remained positive until the 10th week. The total
duration of treatment was 12 weeks. During a 4 months follow up,
no relapse was noted.
S48 Infections in Other Patients and Miscellaneous
Conclusion: Community acquired meningitis by an organism of en-
teric flora in an immunocompromised patient should raise the sus-
picion of hyperinfection syndrome in endemic areas. Since eradi-
cation of parasite may be delayed, repeated stool examination and
prolonged treatment are required.
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Unique Role(s) of Epstein Barr Virus Thymidine Kinase in
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Background: In patients with HIV/AIDS uncontrolled Epstein Barr
Virus (EBV) replication produces high viral loads that expand the
pool of latently infected cells vulnerable to development of B-
lineage tumors: non-Hodgkins lymphoma (NHL) and classic Hodgkin
lymphoma (HL). HAART accompanied by T-cell reconstitution dra-
matically reduced the incidence of EBV+ lymphomas, with the sur-
prising exception of HL. Though EBV+ HL, can be distinguished from
NHL by several criteria, a major difference is the grossly aneu-
ploid nature of the malignant RS cell, a post-germinal center B-cell
characterized by aberrant centrosomes and grossly abnormal chro-
mosomes. Although latent cycle products alone were believed to
promote viral tumorigenesis, accumulating evidence suggests lytic
cycle proteins also play a critical role. The lytic enzyme EBV thymi-
dine kinase (TK) is a modest dT kinase with a large N-terminus of
unknown function. It is present in the virion tegument and interacts
with multiple viral and cellular proteins forming a dominant node
in the viral interactome. How and why these diverse interactions
regulate virion production is entirely unknown. We recently found
that unique among herpesvirus proteins, EBVTK strictly localizes to
centrosomes. Significantly, upon lytic induction EBVTK is detected
in centrosomes containing structural and numerical abnormalities.
The centrosome is the master regulator of the microtubular cy-
toskeleton and controls the physical work of cell division. Minor
perturbations of centrosome content cause errors in chromosome
segregation, cytokinesis and cell cycle regulation, promoting ane-
uploidy and tumorigenesis.
Objective: To uncover the role(s) of EBVTK in control of lytic in-
fection and in development of centrosome abnormalities.
Methods: Biochemical characterization of native enzyme. Con-
struction and expression of wild type TK and a series of TK mu-
tants followed by microscopy to detect localization and pertur-
bation of centrosome/microtubule function in different cell types
(yeast-human).
Results: EBVTK is a phosphoprotein in eukaryotic cells; phosphory-
lation plays distinct roles in different enzyme functions.
Conclusions: EBVTK is a multifunctional protein that performs dis-
tinct roles during different stages of the virus life cycle. TK ex-
pression may predispose to centrosome abnormalities resulting in
aneuploidy as seen in EBV+ HL.
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Antifungal Activity of Posaconazole and Granulocyte
Colony-Stimulating Factor in the Treatment of
Disseminated Zygomycosis in a Neutropenic Murine Model
Stamatis Saoulidis1, Maria Simitsopoulou1, Maria Dalakiouridou1,
Paraskevi Papaioannidou2, Emmanuel Roilides1. 13rd Department
of Pediatrics, Hippokration Hospital, 2Dept. of Pharmacology,
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Background: Zygomycosis is a life-threatening invasive fungal
infection most prevalent among immunocompromised patients.
Posaconazole (POS) is a novel antifungal triazole with activity
against zygomycetes. Granulocyte colony-stimulating factor (G-
CSF) is known to augment neutrophil activity, in vitro, and improve
the effects of antifungal drugs.
Objective: The aim of this study was to develop a neutropenic
murine model of disseminated zygomycosis and evaluate the effi-
cacy of POS alone or in combination with G-CSF.
Methods: Male Balb-c mice were infected via the lateral tail vein
with 5×104 conidia R. microsporus/mL. At 24 hour post-infection
the mice were divided in four groups of five. Each group was
treated with POS (40 mg/kg/day by gavage), or G-CSF (300 mi-
cro g/kg/day subcutaneously), or with the combination of POS+G-
CSF. In the control group, animals were treated with saline. Mice
were rendered neutropenic with cyclophosphamide (200 mg/kg,
intraperitoneally) administered on days –1 and +5. Mortality was
recorded for 10 days and survival was assessed with Kaplan-Meier
curves. The fungal burden of the brain, liver, kidneys and lungs
was evaluated with semi-quantitative cultures and statistical anal-
ysis was performed using arbitrary score units (n`mice).
Results: The mean survival times were 6.56±0.57 days for the con-
trols, 7.53±0.51 days for POS-treated mice (P=0.098 vs controls),
6.93±0.56 days for G-CSF-treated mice (P=NS) and 7.13±0.59
days for POS+G-CSF-treated mice (P=NS). Combination therapy
(P=0.022) as well as POS monotherapy (P=0.037) reduced signifi-
cantly the fungal burden in the kidneys. The reduction of fungal
burden in the rest of the organs was not statistically significant.
Conclusions: Posaconazole monotherapy and POS+G-CSF combina-
tion therapy had a modest efficacy against R. microsporus. Fur-
thermore, POS and combination therapy reduced significantly the
fungal burden in the kidneys, while a moderate reduction of fungal
burden was observed for the rest of the organs. Combining G-CSF
with POS did not substantially affect the antifungal efficacy of POS.
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(1→3)-β-D-Glucan in Cereobrospinal Fluid is a Surrogate
Marker for Detection and Therapeutic Response of
Hematogenous Candida Meningoencephalitis
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Background: Hematogenous Candida meningoencephalitis (HCME)
is a common complication of candidemia in immunocompromised
pediatric patients, particularly neonates, resulting in abscesses,
seizures, ventricular hemorrhage, mental retardation, and death.
CSF cultures are often negative and early diagnosis of HCME is dif-
ficult.
Objectives: To characterize the potential diagnostic utility of CSF
(1→3)-β-D-glucan as a biomarker for the detection and therapeutic
monitoring of HCME.
Methods: The kinetics of expression of (1→3)-β-D-glucan in blood
and CSF was studied in a well-established non-neutropenic rab-
bit model of HCME caused by Candida albicans. Levels of (1→3)-
β-D-glucan were measured by factor G Limulus assay (Cape Cod
Associates). Micafungin (MICA) (0.5 to 32 mg/kg/d IV) and deoxy-
cholate amphotericin B (DAmB) (1 mg/kg/d IV) were administered
to study the effects on expression of (1→3)-β-D-glucan for thera-
peutic monitoring.
Results: Among untreated controls (UC) (n=25), C. albicans es-
